Sleep Hygiene
As the medical community continues to uncover the far-reaching benefits of glucagon-like peptide-1 receptor agonists (GLP-1s), patients suffering from obstructive sleep apnea (OSA) are increasingly looking toward these medications for relief. Drugs originally developed to manage type 2 diabetes—such as Ozempic—have captured public attention for their profound weight-loss side effects. Because excess weight is a … Read More “Navigating Insurance Coverage for Weight-Loss Drugs and Sleep Apnea: What Patients Need to Know About GLP-1s Like Ozempic and Zepbound” »
